Theravance Biopharma, Inc.
SEC CIK 1583107 · tbph · last insider filing 2026-06-23
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mitchell Dean J | Director | filed 2014 - 2026 |
| Pakianathan Deepika | Director | filed 2020 - 2026 |
| Smaldone Alsup Laurie | Director | filed 2018 - 2026 |
| O'Connor Donal | Director | filed 2015 - 2026 |
| Gray Susannah | Director | filed 2023 - 2026 |
| Winningham Rick E | Director · Chief Executive Officer | filed 2014 - 2026 |
| Broshy Eran | Director | filed 2014 - 2025 |
| Grant Jeremy T | Director | filed 2023 - 2025 |
| Malkiel Burton G | Director | filed 2014 - 2023 |
| Kelly James Connor | Director | filed 2023 - 2023 |
| Young William D | Director | filed 2014 - 2022 |
| Whitesides George M | Director | filed 2014 - 2021 |
| Gunderson Robert V JR | Director | filed 2014 - 2021 |
| Molineaux Susan | Director | filed 2015 - 2021 |
| Ringrose Peter S | Director | filed 2014 - 2019 |
| Fore Henrietta | Director | filed 2014 - 2017 |
| Atieh Michael G | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Miller Aine | SVP, Dev & Head of IRE Office | filed 2024 - 2026 |
| Farnum Rhonda | SVP, Comm & Medical Affairs | filed 2021 - 2026 |
| Sawaf Aziz | SVP & Chief Financial Officer | filed 2023 - 2026 |
| Grimaud Brett A. | SVP, Gen Counsel and Secretary | filed 2023 - 2026 |
| Graham Richard A | SVP, RESEARCH & DEVELOPMENT | filed 2020 - 2024 |
| Hindman Andrew A. | SVP, Chief Financial Officer | filed 2019 - 2022 |
| Pitzer Kenneth R | SVP, Prod Strat & Comm Plng | filed 2016 - 2022 |
| Brady ANN | President, TBIL | filed 2019 - 2022 |
| Pasqualone Frank | Sr. Vice President, Operations | filed 2014 - 2021 |
| Worboys Philip D | SVP, Translational Science | filed 2016 - 2021 |
| Sabesan Vijay | SVP, Technical Operations | filed 2019 - 2021 |
| Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | filed 2014 - 2021 |
| Haumann Brett K | VP-Clinical Develop. | filed 2014 - 2021 |
| Hegde Sharathchandra S | SVP, Research | filed 2016 - 2019 |
| Suliman Shehnaaz | SVP, Corp Dev & Strategy | filed 2017 - 2019 |
| Gala Renee D | VP-Finance | filed 2014 - 2018 |
| LEE Junning | Sr. VP, Technical Operations | filed 2014 - 2017 |
| Mammen Mathai | SVP, Research & Early Clin Dev | filed 2014 - 2016 |
| Blum Leonard M | Sr VP, Chief Comm. Officer | filed 2014 - 2016 |
| Jonker Jeffrey David | Senior VP, Corp. & Bus. Dev. | filed 2014 - 2014 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.